Skip to main content
Clinical Trials/NL-OMON56427
NL-OMON56427
Recruiting
Phase 4

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock from Acute Myocardial Infarction: A Multicenter Randomized Trial - NORSHOCK

Cardiologie0 sites776 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Cardiologie
Enrollment
776
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 'Planned early revascularization'
  • 'Systolic blood pressure \<90mmHg for \> 30minutes, OR use of drugs to maintain
  • SBP\>90 mmHg at presentation before randomization'
  • 'Signs of pulmonary congestion'
  • '4\. Signs of impaired organ perfusion with at least one of the following
  • a) Altered mental status
  • b) Cold, clammy skin and extremities
  • c) Oliguria with urine output \<30ml/hour
  • d) Serum lactate \>2\.0 mmol/L'

Exclusion Criteria

  • 'Resuscitation \>30 minutes'
  • 'No intrinsic heart action'
  • 'Cerebral deficit with fixed dilated pupils (not drug\-induced)'
  • 'Mechanical cause of cardiogenic shock'
  • 'Onset of shock \>12 hours'
  • 'Massive lung embolism'
  • 'Shock due to other cause (bradycardia, sepsis, hypovolemia, etc.)'

Outcomes

Primary Outcomes

Not specified

Similar Trials